Mitomycin-C-loaded Alginate Carriers for Bladder Cancer Chemotherapy: In Vivo Studies

Abstract

After a transurethral resection (TUR), chemotherapy and/or immunotherapy is usually applied for 6 to 36 weeks to prevent the recurrence of tumoral tissue. These therapies have many problems, so an alternative pharmacotherapeutic agent delivery system that would supply suitable drug levels for specific time periods was explored. A model pharmacotherapeutic agent, mitomycin-C, delivery system was prepared by using alginate, a mucoadhesive polymer, as the carrier. The alginate carriers were prepared by precipitation and cross-linked with ethylene glycol diglycydyl ether. The alginate carrier precipitation medium (CaCl2), cross-linker and mitomycin-C/alginate ratio were varied to obtain desired attachment to the inner wall of the bladder and provide optimum release rate of the agent. The carrier was cylindrically formed to facilitate insertion for in vivostudies. The mitomycin-C-loaded alginate carriers were implanted into the bladder of New Zealand rabbits. Swelling ratios of the alginate carriers varied from 20% to 45% based on precipitation medium and cross-linker concentration. Ultrasonographic and histopathological findings showed that alginate implants could be kept in position for 1 week.

Keywords

bladder cancer transurethral resection (TUR)alginate mitomycin-C controlled release

Get full access to this article

View all access options for this article.

References

Case, R.A.M. , Hosker, M.E. , McDonald, D.B. and Pearson, J.T. (1954). Tumours of the Urinary Bladder in Workmen Engaged the Manufacture and the Use of Certain Dyestuff Intermediates in the British Chemical Industry: Role of Aniline, Benzidine, Alpha-naphthylamine , Br. J. Ind. Me., 11: 75-75 .

Wynder, E.L. and Goldsmith, R. (1977). The Epidemiology of Bladder Cancer: A Second Look , Cancer, 40: 1246-1246 .

Thompson, I.M. , Peek, M. and Rodriguez, F.R. (1987). The Impact of Cigarette Smoking on Stage, Grade and Number of Recurrences of Transitional Cell Carcinoma of the Bladder , J. Urol.,137: 401-401 .

Prout Jr, G.R. (1976). The Surgical Management of Bladder Carcinoma , Urol. Clin. N. Am., 3: 149-149 .

Lamm, D.L. , Thor, D.E. , Stogdill, V.D. and Radwin, H.M. (1982). Bladder Cancer Immunotherapy , J. Urol., 128: 931-931 .

Catalona, W.J. , Hudson, M.A. , Gillen, D.P. , Andriole, G.L. and Ratliff, T.L. (1987). Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder Cancer , J. Urol., 137: 220-220 .

Highley, M.S. , Oosterom, A.T. , Maes, R.A. and Brujin, E.A. (1999). Intravesical Drug Delivery , Drug Deliv. Sys., 37: 59-59 .

Smart, J.D. (1991). An In Vitro Assessment of Some Mucosa-adhesive Dosage Forms , Int. J. Pharm., 73: 69-69 .

Denkbas, E.B. , Erog.lu, M. , Acar, A. , Özdemir, N. and Öztürk, E. (2004). Preparation and Characterization of Mitomycin-C Loaded Alginate Carriers for Superficial Bladder Cancer Chemotherapy , J. Bioact. Comp. Pol., 19: 1-1, 33-33 .

10.

Lehr, C.M. , Bouwstra, J.A. , Schacht, E.H. and Junginger, H.E. (1992). In Vitro Evaluation of Mucoadhesive Properties of Chitosan and Some Other Natural Polymers , Int. J. Pharm., 78: 43-43 .

11.

Wong, C.F. , Yuen, K.H. and Peh, K.K. (1999). An In-vitro Method for Buccal Adhesion Studies: Importance of Instrument Variables , Int. J. Pharm., 180: 47-47 .

12.

Witschi, C. and Mrsny, R.J. (1999). In Vitro Evaluation of Microparticles and Polymer Gels for Use as Nasal Platforms for Protein Delivery . Pharmaceut. Res., 16: 382-382 .

13.

Erog.lu, M. , Irmak, S. , Acar, A. and Denkbas, E.B. (2002). Design and Evaluation of a Mucoadhesive Therapeutic Agent Delivery System for Postoperative Chemotherapy in Superficial Bladder Cancer , Int. J. Pharm., 235: 51-51 .

14.

Atala, A. , Kim, W. and Paige, K.T. (1994). Endoscopic Treatment of Vesicoureteral Reflux with a Chondrocyte-alginate Suspension , J. Urol., 152: 641-641

15.

Diamond, D.A. and Caldamone, A.A. (1999). Endoscopic Correction of Vesicoureteral Reflux in Children Using Autologous Chondrocytes: Preliminary Results , J. Urol., 162(suppl.): 1185-1185 .

16.

Atala, A. (2000). Tissue Engineering of Artificial Organs , J. Endourol., 14: 49-49 .

17.

Pariente, J.L. , Kim, B.S. and Atala, A. (2002). In Vitro Biocompatibility Evaluation of Naturally Derived and Synthetic Biomaterials Normal Human Bladder Smooth Muscle Cells , J. Urol., 165: 1867-1867 .